Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | -3.99% | -1.90% | -3.48% |
Jun. 07 | Fate Therapeutics, Inc. Appoints J. Scott Wolchko as Principal Financial and Accounting Officer | CI |
May. 31 | Fate Therapeutics, Inc. Announces Chief Financial Officer Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.48% | 411M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Transcript : Fate Therapeutics, Inc., Q3 2022 Earnings Call, Nov 03, 2022